Back to Journals » Cancer Management and Research » Volume 12

Long Noncoding RNA ZFPM2-AS1 Enhances the Malignancy of Cervical Cancer by Functioning as a Molecular Sponge of microRNA-511-3p and Consequently Increasing FGFR2 Expression [Retraction]

Authors Dai J, Wei R, Zhang P, Liu P

Received 25 March 2020

Accepted for publication 25 March 2020

Published 31 March 2020 Volume 2020:12 Pages 2367—2368


Dai J, Wei R, Zhang P, Liu P. Long noncoding RNA ZFPM2-AS1 enhances the malignancy of cervical cancer by functioning as a molecular sponge of microRNA-511-3p and consequently increasing FGFR2  expression. Cancer Manag Res. 2020;12:567– 580.

The Editor-in-Chief and Publisher of Cancer Management and Research wish to retract the published article. 

Concerns were raised that the published article may contain examples of image manipulation, which included the duplication of Figure 2F, column si-NC. The authors provided replacement images for Figure 2F but when asked to verify other data they were unable to provide any raw data relating to the Western blots corresponding to Figures 5D,  6B, 6F, and 7E. As the authors were unable to provide the original raw data the editor agreed the findings of the study were no longer valid and advised for the article to be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper 

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.